Junshi Biotech (01877) had a net loss of 149 million yuan in the first three quarters, a year-on-year decrease of 75%

Zhitongcaijing · 3d ago

According to Zhitong Finance App, Junshi Biotech (01877) announced that in the first three quarters of 2026, operating income was 2,513 billion yuan, up 39.18% year on year; net loss attributable to shareholders of listed companies was 149 million yuan, a year-on-year narrowing 75% year on year; basic loss per share was 0.15 yuan.